Twist Bioscience Corporation TWST

samfanderson1597 Pro+

Currently down 70% from ATH, TWST may be a good buy at these levels. Idk anything about the technology or revenue streams but Jakey mac likes the stock so i charted it out for him. $46-48/share appears as strong support with $66 being sturdy resistance. If 46 breaks, then 40 and 36 are also significant support zones. Could see breakout if we hold above 66, but...

remarkableMind123

The analysis of Twist The Twist at the five wave after that will happen correction

tree5

Fooling around with my TWST chart. I'm long TWST and I'm bored trying to doodle with some ideas for this technical analysis. I have TWST trading sideways (same as other genomic stocks) for the next few months before aiming for the previous ATH again.

ShadaabResearch

Tracing lower bollinger band as MACD and RSI curl up. Bullish downward wedge.

TiagoLeite

TWIST LONG PSOTION

jonwayne02

$TWST Mapping out a target for $TWST. C/H in process? Solid bounce off the fib level, vol profile and EMA. Technicals and oscillators are strong. Price above and nicely aligned with EMA’s. Bullish MACD. RSI is high which would time out with a subwave 4 before testing ATH. NASDAQ:TWST

YoungPearls Pro

time

Mike_y

Charted the top and now calling the bottom of this dip *RESPECT THE TRENDLINE*

AlTorress

This is a signal that TWST's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked back and found 24 similar cases where TWST's RSI Indicator left the overbought zone, and in 20 of them led to a successful outcome. Odds of Success: 83%. Current price $191.80 is above...

Mike_y

Twst setting up with a cup and handle, target would be $211, entry would be over $171

katblat Premium

Buy level is above the volume shelf. Its in the list of genome stocks in my genome watch list. Being careful with this one since I just recently added it to my list.

Andy_D Pro+

Above MA's, respecting trend, still a bullish chart. Twist has essentially invented a new way to “print” DNA onto a microchip so it can be tweaked, analyzed, and researched. This groundbreaking technology makes it possible to reconfigure DNA into something entirely new. DNA is, of course, the code of life. It’s what makes us who we are. By rearranging DNA,...

SimplyCash

Could have reached the end of impulse Wave 5 and setting for an ABC correction pattern.

AlTorress

Over the last three days, Tickeron's A.I.dvisor has detected that TWST's AroonUp green line (see chart) is above 70, while the AroonDown red line is below 30. When the green line goes above 70 while the red line stays below 30, this is an indicator that the stock could be poised for a strong Uptrend. For traders, this could mean going long the stock or exploring...

paulopicaocapelo Pro

Entry price : 138.03 Fundamentals : - Sector: Medical - Biotech - EPS % Chg (Last Qtr): 44% - EPS % Chg (Previous Qtr): 27% - 3 Year EPS Growth Rate: 0% - EPS Est % Chg (Current Yr): 0% - Sales % Chg (Last Qtr): 106% - Sales % Chg (Previous Qtr): 56% - 3-Year Sales Growth Rate: 101% - Annual Pre -Tax Margin: -129.9%

AlTorress

Over the last three days, Tickeron A.I.dvisor has detected that TWST's AroonUp green line (see chart) is above 70, while the AroonDown red line is below 30. When the green line goes above 70 while the red line stays below 30, this is an indicator that the stock could be poised for a strong Uptrend. For traders, this could mean going long the stock or exploring...

SpinTrades Premium

Not long yet but a potential recovery in the works. Interesting company and biotechs have been in favor recently. On watch for a break over the marked fib.

Alexey_Malorodov

Hey, traders. Catch the long for today. Let's take a close look at the chart. 1. On 08.04.2020, after a strong decline, the long player came into force. Having gained a position, he pushed the price upwards. 2. Once again, we see the price going from level to level in a channel, however, after the rise there is no rebound. For 12 days, a new position was...